| PharmaSUG |
2026 |
Linear versus Log-Log Confidence Intervals for Kaplan-Meier Survival Estimates: Statistical Rationale and Practical Implementation using SAS 9.4 |
Prayag Shah |
source |
8 |
| PharmaSUG |
2026 |
Oncology Solid Tumor Subcutaneous vs Intravenous Late-stage Study Analysis |
Sumanjali Mangalarapu, Chuqing Chen, Anilkumar Anksapur |
source |
11 |
| PHUSE US |
2026 |
Group, Collapse, Repeat: A Dynamic SAS Macro for Stratification Pooling in Oncology Efficacy Analysis |
Venkatesh Burla |
source presentation source |
9 |
| PHUSE US |
2026 |
Interactive and Instant: GenAI-Driven Creation of Clinical Trial Applications |
Marcin Dubel |
source presentation source |
12 |
| PHUSE US |
2026 |
Mapping Minimal Residual Disease (MRD) Biomarker Data in Hematologic Malignancies: Clinical Significance and Data Standards in SDTM and ADaM |
Jyothi Nelakurthi |
source presentation source |
8 |
| PHUSE US |
2026 |
Practical Survival Analysis Techniques for Clinical Trials Using SAS |
Xue Ding, Tianchen Xu |
source presentation source |
10 |
| PHUSE APAC |
2026 |
Illustrating treatment switching using Rank preserving structural failure time model in Oncology study |
Swarupa Changan |
source presentation source |
11 |
| PharmaSUG |
2025 |
ADaM Pet Peeves: Things Programmers Do That Make Us Crazy |
Sandra Minjoe, Nancy Brucken |
source |
13 |
| PharmaSUG |
2025 |
Implementation of the inverse probability of censoring weighting (IPCW) Model in Oncology Trials |
Mei Huang, Shibani Harite, Haijun Ma, Linsong (Athena) Zhang |
source |
17 |
| PharmaSUG |
2025 |
Mastering the Maze of Oncology Endpoints: A Unified SAS Approach for Randomized Controlled Trial Analysis |
Yuxin Wang, Kelly Chao, Wenqing Yu, Hongbing Jin |
source |
11 |
| PharmaSUG |
2025 |
Sensitivity Analysis for Overall Survival |
Binal Mehta, Patel Mukesh |
source |
13 |
| PharmaSUG |
2025 |
Visually Exploring Kaplan-Meier Curves Using SAS GTL and R survminer |
Yang Gao |
source |
5 |
| PHUSE US |
2025 |
An Intuitive Way to Derive the Last Known Alive Date in R |
Marckenley Mercie, Diana Tai |
source presentation source |
12 |
| PHUSE US |
2025 |
Revolutionising Cancer Trials with Adaptive Designs and Bayesian Analysis |
Navneet Jha |
source presentation source |
11 |
| PHUSE US |
2025 |
SAS Programming approach for adjustment of treatment switching using Two-Stage Method |
Mani Mudumba |
source presentation source |
13 |
| PharmaSUG |
2024 |
Oncology ADaM Datasets Creation Using R Programming: A Comprehensive Approach |
Ishwar Chouhan |
source |
29 |
| PharmaSUG |
2024 |
Programming Considerations in Deriving Progression-Free Survival on Next-Line Therapy (PFS2) |
Alec McConnell, Yun Peng |
source |
5 |
| PHUSE US |
2024 |
Comparison of Standard Log-Rank Test with Selected Alternatives |
Elena Valkanova, Bulat Fatykhov |
source poster source |
18 |
| PHUSE EU |
2023 |
Efficacy Endpoints in Adjuvant and Neo-Adjuvant Oncology Trials |
Yuliia (Piddubna) Cherednichenko, Anna Amosova |
source presentation source |
15 |
| PHUSE EU |
2023 |
Real-World Outcomes and Biomarker Testing in Cancer Patients: Exploration of a Novel Genetic Database from Routine Clinical Practice in England |
Alexandrina Lambova, Fiona Ingleby |
source presentation source |
5 |
| PharmaSUG |
2023 |
Guidelines for the Statistical Analysis in German Dossier Submissions |
Meiling Gao, Xi Qian, Hui Mao |
source |
8 |
| PharmaSUG |
2023 |
Survival Methods for Crossover in Oncology Trials |
Brian Mosier |
source |
18 |
| PHUSE US |
2022 |
Jumping on the Real-world Data (RWD)/Real-world Evidence (RWE) Bandwagon? A Guide for Statistical Programmers to Understand Payer Claims Data [presentation] |
Rachana Agarwal |
source video |
13 |
| PHUSE EU |
2021 |
Statistical Training for Health Technology Assessment Statistical Programmers |
Anastasia Kokoreva, William Malbecq |
source video presentation source |
7 |
| PHUSE EU |
2021 |
Using R - TFL Generation with Custom Functions [poster] |
Jem Chang, Vikram Kasarala |
source video |
1 |
| PharmaSUG |
2020 |
%MVMODELS: a Macro for Survival and Logistic Analysis |
Jeffrey P. Meyers |
source |
23 |
| PHUSE US |
2020 |
CDISC's ADTTE Domain: Time-to-Event Analysis From a Programmer's Point of View |
Frieder Wolff, Vitali Gering |
source poster source |
8 |
| PHUSE US |
2020 |
Data Standards Used for Electronic Submission of Real-World Evidence in New Drug Application (NDA) |
Nicole Thorne, Kathy Wu |
source presentation source |
10 |
| PHUSE US |
2020 |
Let Us Trace Back to the Beginning from the End |
Madhusudhan Reddy Papasani, Swathi Kotla |
source presentation source |
12 |
| PHUSE EU |
2019 |
Don't Dream It, Be It Harnessing SAS GTL to Produce Customized Composite Graphics |
Neville Cope |
source presentation source |
10 |
| PharmaSUG |
2019 |
F2Plots: Visualizing relative treatment effects in cancer clinical trials |
Yellareddy Badduri |
source |
9 |
| PharmaSUG |
2019 |
Framework for German Dossier Submissions |
Kriss Harris |
source |
8 |
| PharmaSUG |
2019 |
Jump Start your Oncology knowledge |
Xiaoyin Zhong, Feng Liu |
source |
9 |
| PharmaSUG |
2019 |
Learning SAS GTL Basics with Practical Examples |
Jinit Mistry |
source |
12 |
| PharmaSUG |
2019 |
Useful SAS techniques in Efficacy Analysis for Oncology studies |
Joy Zeng |
source |
21 |
| PharmaSUG |
2019 |
Visualize Overall Survival and Progression Free Survival at the Same Time! |
Kriss Harris |
source |
2 |
| SGF |
2019 |
Framework for German Dossier Submissions |
Kriss Harris |
source |
9 |
| SGF |
2019 |
Using SAS Macros to Analyze Lifetime Data with Left Truncation |
Zhen-Huan Hu |
source |
11 |
| PHUSE US |
2019 |
Dashboarding Analytics for Oncology Endpoint Data Using SAS |
Vidya Muthukumar |
source presentation source |
7 |
| PHUSE US |
2019 |
Misuse and Misapplication in Statistical Data Analysis - A Topic that Never Goes Out of Style |
Corinna Miede |
source presentation source |
12 |
| PHUSE US |
2019 |
The Power of Sharing Clinical Data: Real Projects with Real Impacts |
David Handelsman |
source presentation source |
6 |
| PHUSE EU |
2018 |
Forest Plots in Survival Subgroup Analyses |
Michael Brockmann, Julia Benzing |
source presentation source |
11 |
| PHUSE EU |
2018 |
Implementation of Data Cut Off in Analysis of Clinical Trials |
Ann Croft |
source presentation source |
13 |
| PHUSE EU |
2018 |
Methods for Survival Analysis with Competing Risks |
Laura Marquis, Leonie Wagner |
source presentation source |
8 |
| PHUSE US |
2018 |
Unleashing Potential of Graphs for Oncology Trials |
Manoj Pandey |
source presentation source |
12 |
| PharmaSUG |
2018 |
ADINTDT and ADTTE for Survival Sweep in Oncology Studies |
Christine S Teng, Wenyu Hu |
source |
6 |
| PharmaSUG |
2018 |
Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYPE |
Kamleshkumar Patel |
source |
12 |
| PharmaSUG |
2018 |
Implementation of Data Cut Off in Analysis of Clinical Trials |
Mei Dey |
source |
15 |
| PharmaSUG |
2018 |
Implementing the Rank-Preserving Structural Failure Time Model in SAS and R |
Bradford J. Danner, Indrani Sarkar |
source |
8 |
| PharmaSUG |
2018 |
Sense and Censorability: Learn censoring techniques with ADTTE for your survival |
Shilpakala Vasudevan |
source |
12 |
| PHUSE EU |
2016 |
Considerations in the Use of Propensity Scoresin Observational Studies |
Lawrence Rasouliyan, Estel Plana |
source presentation source |
17 |
| PharmaSUG |
2016 |
Programming Support for Exposure-Response Analysis in Oncology Drug Development |
Peter Lu, Hong Yan |
source |
8 |
| PharmaSUG CN |
2015 |
Survival Plots using SAS PROC LIFETEST, GPLOT, and SGPLOT: What are their difference? |
Ka Chun Chong, Benny Chung-Ying Zee |
|
8 |
| SGF |
2015 |
A Set of SAS Macros for Generating Survival Analysis Reports for Lifetime Data with or without Competing Risks |
Zhen-Huan Hu |
source zip |
6 |
| SGF |
2015 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
source |
20 |
| PHUSE EU |
2014 |
Checking Symmetry in Predefined Time Assessments |
Antonio Nieto, José Luis Jiménez Moro |
source presentation source |
9 |
| PHUSE EU |
2014 |
Evaluating the Tradeoff between Quality of Life through Quality-Adjusted Survival Analysis |
Lawrence Rasouliyan |
source presentation source |
12 |
| PHUSE EU |
2014 |
Inverse Probability of Censoring Weighting for Selective Crossover in Oncology Clinical Trials |
José Luis Jiménez Moro, Javier Gómez Garcia |
source presentation source |
5 |
| MWSUG |
2014 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
|
20 |
| PharmaSUG CN |
2014 |
Design and Construct Efficacy Analysis Datasets in Later Phase Oncology Study |
Huadan Li, Changhong Shi |
|
9 |
| PharmaSUG |
2014 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
source |
19 |
| PharmaSUG |
2014 |
Standardization of Confidence Intervals in PFS Tables - a Macro Approach |
John Saida Shaik, Boxun Zhang |
source |
4 |
| PHUSE EU |
2013 |
Efficacy Endpoints in Oncology |
Angelo Tinazzi |
source |
9 |
| PHUSE EU |
2013 |
Oncology Endpoints: An Unexpected Journey |
Waseem Jugon, Mijanur Rahman |
source |
12 |
| PHUSE EU |
2012 |
Bootstrap simulations to estimate Overall Survival based on the distribution of a historical control |
Antonio Nieto, Javier Gómez |
source presentation source |
7 |
| WUSS |
2010 |
Survival 101: Reporting Survival Curves Using Sample Data from the Colorectal Cancer Outcomes Database |
Anna ter Veer |
source |
11 |
| WUSS |
2008 |
Surviving Left Truncation Using PROC PHREG |
Aimee Foreman, Ginny Lai, Dave P. Miller |
source |
8 |
| PHUSE EU |
2008 |
RECIST Temptation |
Paul Jenkins |
source |
8 |
| MWSUG |
2008 |
Creating Macros for Survival Data in Oncology Study |
Jagannath Ghosh |
|
8 |
| PharmaSUG |
2007 |
%SurvTab: A SAS Macro to Make Survival Analysis Easier |
Yinmei Zhou, St. Jude Children's |
|
15 |
| SEUGI |
1997 |
%SUPLANA - a powerful SAS macro routine for survival analysis |
Angelo Tinazzi, Valter Torri |
source |
6 |